Eli Lilly and Company
LLY · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $695,267 | $524,266 | $347,615 | $263,418 |
| - Cash | $3,268 | $2,819 | $2,067 | $3,819 |
| + Debt | $33,644 | $25,225 | $16,239 | $16,885 |
| Enterprise Value | $725,643 | $546,673 | $361,786 | $276,484 |
| Revenue | $45,043 | $34,124 | $28,541 | $28,318 |
| % Growth | 32% | 19.6% | 0.8% | – |
| Gross Profit | $36,624 | $27,042 | $21,912 | $21,006 |
| % Margin | 81.3% | 79.2% | 76.8% | 74.2% |
| EBITDA | $15,228 | $8,568 | $8,661 | $8,043 |
| % Margin | 33.8% | 25.1% | 30.3% | 28.4% |
| Net Income | $10,590 | $5,240 | $6,245 | $5,582 |
| % Margin | 23.5% | 15.4% | 21.9% | 19.7% |
| EPS Diluted | 11.71 | 5.8 | 6.57 | 5.85 |
| % Growth | 101.9% | -11.7% | 12.3% | – |
| Operating Cash Flow | $8,818 | $4,240 | $7,586 | $7,366 |
| Capital Expenditures | -$8,404 | -$7,392 | -$2,985 | -$1,978 |
| Free Cash Flow | $414 | -$3,152 | $4,600 | $5,388 |